Job Description
The Sr Associate II, Drug Safety is accountable for the end-to-end operational management of Adverse Events of Special Interest (AESIs) across the product lifecycle, including both Clinical Trial and Post-Marketing settings. This role serves as a central coordination hub for internal stakeholders, ensuring timely identification, escalation, and communication of AESIs across the Safety Organization. The Sr Associate II, Drug Safety is accountable for overseeing day-to-day AESI case handling activities outsourced to a vendor, ensuring that case identification, processing, and follow-up are conducted in accordance with Biogen procedures. This includes ongoing vendor oversight, issue resolution, and performance monitoring. Principle responsibilities Ensures all AE case processing, in both the Post-Marketing and Clinical Trial settings, is conducted in compliance with regulatory requirements, corporate and departmental procedure and data handling conventions by maintaining and executing oversight plans for vendors (CROs) with case processing responsibilities. Monitors Biogen Global Safety Database (GSD) and identifies and communicates to appropriate internal stakeholders on events of interest in both Post-Marketing and Clinical Trial settings Monitors the compliance and health of the case processing workflow continuously through the use of various monitoring reports Monitors the quality of outsourced AESI case processing activities, ensuring high-quality, clinically appropriate queries are developed and issued for AESIs. Supports PML adjudication meetings and is accountable for the presentation of the AESI clinical data to the adjudication committee and documentation and dissemination of key decisions to stakeholders Supports team leadership in execution of AESI -related activities, including contribution to regulatory deliverables for PML, and internal analyses (e.g. FDA AEMS). Qualifications Bachelor's degree in nursing, pharmacy, or other health related profession 2+
